T PROSTATE is the site of two common diseases in aging men, benign prostatic hyperplasia (BPH) and prostate cancer (CaP). Although mortality rates due to BPH are less than 0.5 per 100,000 population, this disease affects the quality of life and health care costs exceed 4 billion dollars per year. If a man in the United States lives to be 80 yr of age, there is a 25% chance that he will require ...

A number of new treatment modalities for benign prostatic hyperplasia (BPH) have been introduced in these days: for example, laser ablation, alpha-adrenergic blocker, antiandrogens, hyperthermia, stenting and balloon dilation. The author basically mentioned the personal experiences in some of these modalities, and gave a general review on their effectiveness and safety. Also pointed out were a ...

Watchful waiting is recommended for patients with benign prostatic hyperplasia (BPH) whose clinical symptoms do not affect their quality of life. Use a validated patient questionnaire, such as the American Urological Association's Symptom Index, to establish the severity of BPH symptoms and follow their progression. alpha-Adrenergic blockers (either selective or nonselective) or 5-alpha reducta...

BACKGROUND Benign prostatic hyperplasia (BPH) is non-cancerous condition of enlargement of the prostate, a common occurrence in older men. The immature fruits of Poncirus trifoliata (L.) Rafinesque (Rutaceae), Ponciri Fructus are widely used in traditional oriental medicine for the therapy of various diseases. However, little is known about the mechanism underlying the pathogenesis of BPH. In t...

BACKGROUND Benign prostatic hyperplasia (BPH) is a result of urogenital aging. Recent studies suggest that an age-related impairment of the blood supply to the lower urinary tract plays a role in the development of BPH and thus may be a contributing factor in the pathogenesis of BPH. The canine prostate is a model for understanding abnormal growth of the human prostate gland. We studied the eff...

Hypothesis / aims of study There is increasing evidence showing that prostatic inflammation is associated with the development of histological benign prostatic hyperplasia (BPH) and male lower urinary tract symptoms (LUTS) [1]. It has also been reported that dutasteride, which inhibits 5α-reductase, might have anti-inflammatory effects in the prostate of patients with lower urinary tract sympto...

Benign prostatic hyperplasia (BPH) is one of the most common conditions experienced by aging males and a frequent cause bladder outlet obstruction macroscopic haematuria. “Giant hyperplasia” (GPH) term that describes rare cases extremely enlarged prostate glands, weighing up to 500g. Typically, patients with GPH have severe symptoms seek medical care treat their voiding complaints. an uncommon ...

Purpose: To investigate the effect of virgin coconut oil, lauric acid and myristic on serum prostatic androgens in testosterone-induced hyperplasia.Methods: Benign hyperplasia (BPH) was induced animals by repeated subcutaneous injection testosterone propionate (5 mg/kg) at inguinal region once a day for 28 days. Thereafter, BPH treated 56 days oral administration acid. Following treatment perio...

benign prostatic hyperplasia (bph) is a common disease in human that gradual overgrowth of the prostate gland leads to impinge on the urethra with impairment in urinary function. numerous plants improve uncontrolled growth of the prostate gland and improve urinary tract symptoms associated with bph. in this study, 25 healthy adult male wistar rats were divided randomly in five groups: g1 (contr...